Topics

Tempo Bioscience, Inc. Company Profile

21:50 EDT 21st September 2019 | BioPortfolio


News Articles [386 Associated News Articles listed on BioPortfolio]

Tempo Bioscience Expands Patient-Relevant iPSC-Derived Cell Models

Tempo Bioscience, Inc. (“Tempo”) a privately-held biotechnology company based in San Francisco, California, has released new human induced pluripotent stem cell (iPSC) derived...

BioTrace Medical secures CE mark for Tempo Lead used in intracardiac pacing

BioTrace said that it has designed Tempo Temporary Pacing Lead to deliver safer, more secure and stable pacing to reduce intraprocedural complications, including perforation and valve embolization. In...

The mode and tempo of synthetic evolution: Author Andrew Ellington goes #behindthepaper https://bioengineeringcommunity.nature.com/badges/562-nature-biotech/posts/50081-the-mode-and-tempo-of-synthetic-evolution …

The mode and tempo of synthetic evolution: Author Andrew Ellington goes #behindthepaper https://bioengineeringcommunity.nature.com/badges/562-nature-biotech/posts/50081-the-mode-and-tempo-of-synthet...

Aytu BioScience, Inc.: Aytu BioScience Appoints Steven Boyd to the Company's Board of Directors

ENGLEWOOD, CO / ACCESSWIRE / April 16, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant m...

Aytu BioScience, Inc.: Aytu BioScience Reports 291% Revenue Growth in Q3 FY19

Company Posts Highest Ever Quarterly Revenue ENGLEWOOD, CO / ACCESSWIRE / May 14, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel pr...

Aytu BioScience, Inc.: Aytu BioScience to Report Fiscal FY 2019 Results and Business Update

ENGLEWOOD, CO / ACCESSWIRE / September 19, 2019 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient ...

Aytu BioScience, Inc.: Aytu BioScience to Report Fiscal Third Quarter 2019 Results and Business Update

Live Conference Call and Webcast Scheduled for May 14, 2019, at 9:00 a.m. ET ENGLEWOOD, CO / ACCESSWIRE / May 7, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focu...

EastWest Bioscience Inc.: EastWest Bioscience signs Letter of Intent with Benchmark Botanics

VANCOUVER, BC / ACCESSWIRE / June 10, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces that it has signed a Letter of Intent for a J oint V enture with Benchmark Bot...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Idkit hp one [exalenz bioscience ltd.]

Package Insert IDkit:Hp™ for the Exalenz BreathID® System BREATH TEST FOR DETECTION of H. pylori

Natesto [aytu bioscience, inc.]

These highlights do not include all the information needed to use NATESTO safely and effectively. See full prescribing information for NATESTO.Natesto (testosterone) nasal gel CIII Initial U.S. Approv...

Jynarque [otsuka america pharmaceutical, inc.]

These highlights do not include all the information needed to use JYNARQUE safely and effectively. See full prescribing information for JYNARQUE. JYNARQUE (tolvaptan) tablets for oral use Initial U.S....

PubMed Articles [120 Associated PubMed Articles listed on BioPortfolio]

TEMPO-Me: An Electrochemically Activated Methylating Agent.

Bench- and air-stable 1-methoxy-2,2,6,6-tetramethylpiperidine (TEMPO-Me) is relatively unreactive at ambient temperature in the absence of an electrochemical stimulus. In this report, we demonstrate t...

Transparent bionanocomposite films based on konjac glucomannan, chitosan, and TEMPO-oxidized chitin nanocrystals with enhanced mechanical and barrier properties.

The development of biopolymer-based films for food packaging is increasing owing to their environmental appeal, renewability, and biodegradability. In this study, transparent and biodegradable konjac ...

In vitro investigation of the influence of nano-cellulose on starch and milk digestion and mineral adsorption.

Three types of nanocellulose, namely nano-fibrilated cellulose (NFC, also called cellulose nano-fibrils (CNF)), TEMPO (2,2,6,6-tetramethylpiperidine-1-oxyl radical) oxidized cellulose nano-fibrils (TE...

Transformation of atenolol by a laccase-mediator system: Efficiencies, effect of water constituents, and transformation pathways.

In this study, we investigated the transformation of atenolol (ATL) by the naturally occurring laccase from Trametes versicolor in aqueous solution. Removal efficiency of ATL via laccase-catalyzed rea...

Mito-TEMPO, a mitochondria-targeted antioxidant, prevents N-nitrosodiethylamine-induced hepatocarcinogenesis in mice.

Oxidative stress and mitochondrial dysfunction play a significant role in hepatocarcinogenesis. Mitochondria are source organelle as well as target for free radicals. The oxidative damage to mitochond...

Clinical Trials [21 Associated Clinical Trials listed on BioPortfolio]

Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome

Metabolic syndrome increases the risk for development of heart disease. Another condition associated with metabolic syndrome is fatty liver disease which is also referred to as nonalcoholi...

The Music Activity INTervention for Adherence Improvement Through Neurological Entrainment - II

This study (MAINTAIN -II) aims to examine the effect of audio playlists [with or without Rhythmic Auditory Stimulation (RAS)] on the weekly volume of physical activity. Participants will b...

Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT

The primary purpose of this study is to test the efficacy of Lisdexamfetamine in Adults With Attention Deficit Hyperactivity Disorder (ADHD) and Sluggish Cognitive Tempo (SCT). This is a p...

The Effect of Distractive Auditory Stimuli (Music) on Dyspnea and Anxiety During Exercise in Adults With Chronic Respiratory Diseases

The objective of this study is to look at the effects of distractive auditory stimuli (DAS) on reducing dyspnea intensity and related anxiety and increasing exercise tolerance. Investigato...

Efficacy of Tolvaptan on ADPKD Patients

A longitudinal clinical study to investigate the changes before and after administration of tolvaptan in patients whose clinical course is monitored prior to the approval of tolvaptan will...

Companies [325 Associated Companies listed on BioPortfolio]

Tempo Bioscience, Inc.

Tempo Automation

Tempo Automation is the world’s fastest electronics manufacturer for prototyping and low-volume production of printed circuit board assemblies. Tempo is changing the way elec...

The Idaho Bioscience Association

The Idaho Bioscience Association is a non-profit organization that brings together corporate, academic and political leaders to educate the public and to promote bioscience activities in the state. B...

Sprint Bioscience

Sprint Bioscience AB (publ) is part of the new Swedish pharmaceutical industry. The company has the goal to develop drug candidates for the global pharmaceutical market within the...

Bioscience Bridge, LLC

Bioscience Bridge, LLC is a global technology transfer agency. We accelerate the connections of university-based bioscience research with commercial development opportunities. We are unique because we...

More Information about "Tempo Bioscience, Inc." on BioPortfolio

We have published hundreds of Tempo Bioscience, Inc. news stories on BioPortfolio along with dozens of Tempo Bioscience, Inc. Clinical Trials and PubMed Articles about Tempo Bioscience, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tempo Bioscience, Inc. Companies in our database. You can also find out about relevant Tempo Bioscience, Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record